Coeptis Therapeutics Stock Market Value
| COEP Stock | USD 0.20 0.01 5.26% |
| Symbol | Coeptis |
Coeptis Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Coeptis Therapeutics. If investors know Coeptis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Coeptis Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Quarterly Revenue Growth 15.637 | Return On Assets (1.87) | Return On Equity (14.81) |
The market value of Coeptis Therapeutics is measured differently than its book value, which is the value of Coeptis that is recorded on the company's balance sheet. Investors also form their own opinion of Coeptis Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Coeptis Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Coeptis Therapeutics' market value can be influenced by many factors that don't directly affect Coeptis Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Coeptis Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Coeptis Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Coeptis Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Coeptis Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Coeptis Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Coeptis Therapeutics.
| 12/13/2022 |
| 12/02/2024 |
If you would invest 0.00 in Coeptis Therapeutics on December 13, 2022 and sell it all today you would earn a total of 0.00 from holding Coeptis Therapeutics or generate 0.0% return on investment in Coeptis Therapeutics over 720 days. Coeptis Therapeutics is related to or competes with LMF Acquisition, ZyVersa Therapeutics, Sonnet Biotherapeutics, Revelation Biosciences, Clearmind Medicine, Quoin Pharmaceuticals, and Genelux Common. Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharma... More
Coeptis Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Coeptis Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Coeptis Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.72 | |||
| Information Ratio | 0.0051 | |||
| Maximum Drawdown | 19.81 | |||
| Value At Risk | (5.56) | |||
| Potential Upside | 6.25 |
Coeptis Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Coeptis Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Coeptis Therapeutics' standard deviation. In reality, there are many statistical measures that can use Coeptis Therapeutics historical prices to predict the future Coeptis Therapeutics' volatility.| Risk Adjusted Performance | 0.0379 | |||
| Jensen Alpha | 0.0131 | |||
| Total Risk Alpha | (0.53) | |||
| Sortino Ratio | 0.0037 | |||
| Treynor Ratio | 0.14 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Coeptis Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Coeptis Therapeutics Backtested Returns
Currently, Coeptis Therapeutics is extremely dangerous. Coeptis Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0199, which signifies that the company had a 0.0199% return per unit of standard deviation over the last 3 months. We have found twenty-eight technical indicators for Coeptis Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Coeptis Therapeutics' mean deviation of 2.72, and Risk Adjusted Performance of 0.0379 to double-check if the risk estimate we provide is consistent with the expected return of 0.0813%. Coeptis Therapeutics has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.06, which signifies a somewhat significant risk relative to the market. Coeptis Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Coeptis Therapeutics is expected to follow. Coeptis Therapeutics right now shows a risk of 4.08%. Please confirm Coeptis Therapeutics information ratio and the relationship between the maximum drawdown and rate of daily change , to decide if Coeptis Therapeutics will be following its price patterns.
Auto-correlation | 0.50 |
Modest predictability
Coeptis Therapeutics has modest predictability. Overlapping area represents the amount of predictability between Coeptis Therapeutics time series from 13th of December 2022 to 8th of December 2023 and 8th of December 2023 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Coeptis Therapeutics price movement. The serial correlation of 0.5 indicates that about 50.0% of current Coeptis Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.5 | |
| Spearman Rank Test | 0.66 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Coeptis Therapeutics lagged returns against current returns
Autocorrelation, which is Coeptis Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Coeptis Therapeutics' stock expected returns. We can calculate the autocorrelation of Coeptis Therapeutics returns to help us make a trade decision. For example, suppose you find that Coeptis Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Coeptis Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Coeptis Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Coeptis Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Coeptis Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Coeptis Therapeutics Lagged Returns
When evaluating Coeptis Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Coeptis Therapeutics stock have on its future price. Coeptis Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Coeptis Therapeutics autocorrelation shows the relationship between Coeptis Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Coeptis Therapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Coeptis Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Coeptis Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coeptis Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Coeptis Stock
| 0.59 | A | Agilent Technologies Sell-off Trend | PairCorr |
| 0.56 | ME | 23Andme Holding Upward Rally | PairCorr |
| 0.41 | DOMH | Dominari Holdings | PairCorr |
The ability to find closely correlated positions to Coeptis Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Coeptis Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Coeptis Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Coeptis Therapeutics to buy it.
The correlation of Coeptis Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Coeptis Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Coeptis Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Coeptis Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Coeptis Stock Analysis
When running Coeptis Therapeutics' price analysis, check to measure Coeptis Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coeptis Therapeutics is operating at the current time. Most of Coeptis Therapeutics' value examination focuses on studying past and present price action to predict the probability of Coeptis Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coeptis Therapeutics' price. Additionally, you may evaluate how the addition of Coeptis Therapeutics to your portfolios can decrease your overall portfolio volatility.